BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berry CM. Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System. Cytokine Growth Factor Rev 2016;31:83-90. [PMID: 27544015 DOI: 10.1016/j.cytogfr.2016.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Denney L, Ho LP. The role of respiratory epithelium in host defence against influenza virus infection. Biomed J 2018;41:218-33. [PMID: 30348265 DOI: 10.1016/j.bj.2018.08.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
2 Cristina G, Antonela AS, Ruxandra OM, Antohe I, Petronela FA, Anton AI, Doina TE. Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment. ARS Medica Tomitana 2018;24:152-6. [DOI: 10.2478/arsm-2018-0027] [Reference Citation Analysis]
3 Schlaepfer E, Fahrny A, Gruenbach M, Kuster SP, Simon V, Schreiber G, Speck RF. Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects. mSphere 2019;4:e00637-18. [PMID: 30760614 DOI: 10.1128/mSphere.00637-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
4 Setthawongsin C, Tangkawattana S, Rungsipipat A, Techangamsuwan S. In vitro Effect of Recombinant Feline Interferon-Ω (rFeIFN-Ω) on the Primary CanineTransmissible Venereal Tumor Culture. Front Vet Sci 2019;6:104. [PMID: 31024941 DOI: 10.3389/fvets.2019.00104] [Reference Citation Analysis]
5 Sui Y, Li J, Venzon DJ, Berzofsky JA. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage. Front Immunol 2021;12:658428. [PMID: 34149696 DOI: 10.3389/fimmu.2021.658428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rackov G, Shokri R, De Mon MÁ, Martínez-A C, Balomenos D. The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential. Front Immunol 2017;8:493. [PMID: 28533774 DOI: 10.3389/fimmu.2017.00493] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
7 Berry CM. Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies? Hum Vaccin Immunother 2018;14:796-9. [PMID: 28854120 DOI: 10.1080/21645515.2017.1363135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 de Freitas AC, de Oliveira THA, Barros MR Jr, Venuti A. hrHPV E5 oncoprotein: immune evasion and related immunotherapies. J Exp Clin Cancer Res 2017;36:71. [PMID: 28545552 DOI: 10.1186/s13046-017-0541-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
9 Jeon YJ, Lim JH, An S, Jo A, Han DH, Won T, Kim D, Rhee C, Kim HJ. Type III interferons are critical host factors that determine susceptibility to Influenza A viral infection in allergic nasal mucosa. Clin Exp Allergy 2018;48:253-65. [DOI: 10.1111/cea.13082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S, Smith AG, Li Y, Liu W, Avitto AN, DeVoto JC, Connell J, Fenton-May AE, Pellegrino P, Williams I, Papasavvas E, Lorenzi JCC, Salantes DB, Mampe F, Monroy MA, Cohen YZ, Heath S, Saag MS, Montaner LJ, Collman RG, Siliciano JM, Siliciano RF, Plenderleith LJ, Sharp PM, Caskey M, Nussenzweig MC, Shaw GM, Borrow P, Bar KJ, Hahn BH. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci Transl Med 2021;13:eabd8179. [PMID: 33441429 DOI: 10.1126/scitranslmed.abd8179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]